As of now, Haier Biomedical and its subsidiaries have achieved a total of 361 approved patents, awarded the National Prize for Progress in Science and Technologynational in China. Our core R & D personnel have led or engaged in the drafting of 9 national and industry standards, basically covering all biomedical cryogenic storage products. Furthermore, Haier Biomedical participated in the drafting of World Health Organization (WHO) international standards, showing true leadership and development for the industry.

Haier Biomedical leads a new revolution in traditional manufacturing as well as innovative technology development. In the context of rapid development of the Internet of Things, Haier Biomedical has comprehensively promoted the integration and innovation of IoT technology and low-temperature storage technology. Combining IoT software and hardware based on network communication and radio frequency identification technology with self-developed low-temperature storage products. Haier Biomedical updated traditional storage devices to the IoT solution, which effectively meets the needs of users such as clinical blood use, vaccination, and biobank application building the leading IoT technology ecosystem.

Up to now, Haier Biomedical's IoT solutions are untilized in major national strategic projects such as CMDP, CNGB, and Chinese Human Genetic Resource Bank, and covers Beijing 301 Hospital, Shanghai Ruijin Hospital, Xi'an Jiaotong University First Affiliated Hospital, and Sichuan University West China Hospital Changsha Xiangya Hospital, First Affiliated Hospital of China Medical University, National Cardiovascular Center & Fuwai Hospital and other key top three hospitals. Moreover, Haier Biomedical's Vaccine Network is now used in a great number of inoculation sitesand building full-coverage smart city vaccine network in many areas across China. The company's solutions are now used also in international markets such as the British biological sample bank, the Swedish Karolinska Institute of Technology, Denmark, Italian public hospitals and multiple other examples from developed markets.

With superior product quality, flexible solutions and leading technology, Haier Biomedical has won the trust and recognition of comsumers widely distributed in more than 120 countries and territories. Haier Biomedical Insists on the intelligent protection of life,by empowering science and technology, and is commited to providing the best products and solutions, enhancing the advancement of world's biological technology and research.